Coping Peer Intervention for Adherence
Launched by RUSH UNIVERSITY MEDICAL CENTER · Jul 23, 2010
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
High rates of asthma morbidity and mortality among inner-city African American and Hispanic adolescents demand urgent intervention. To address this disparity, the investigators have designed a culturally sensitive intervention aimed at improving adherence to daily controller medications for asthma, and ultimately reduce asthma exacerbation risk, that fits easily into adolescents' chaotic lifestyles.
The proposed study is a behavioral randomized controlled trial that tests if a coping peer intervention can increase adherence to asthma controller medications among urban African American and ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identify as African American or Hispanic
- • 11-16 years of age
- • Have persistent asthma
- • Be on a prescription daily inhaled steroid medication for asthma
- Exclusion Criteria:
- • Candidate refusal
- • Presence of other co-morbidities that could interfere with study participation
- • greater than 47% adherence to daily inhaled steroid medication as measured at baseline using the Doser CT
Trial Officials
Giselle S Mosnaim, MD, MS
Principal Investigator
Rush University Medical Center
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
